Vericel Co. (NASDAQ:VCEL – Get Free Report) shares were up 2.9% during mid-day trading on Monday . The company traded as high as $34.14 and last traded at $34.14. Approximately 15,560 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 351,357 shares. The stock had previously closed at […]
StockNews.com assumed coverage on shares of Vericel (NASDAQ:VCEL – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other research analysts have also recently issued reports about the company. BTIG Research raised Vericel from a neutral rating to a buy rating […]
Perkins Capital Management Inc. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 3.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,867 shares of the biotechnology company’s stock after selling 1,000 shares during the period. […]
Citigroup Inc. raised its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 109,391 shares of the biotechnology company’s stock after buying an additional 4,088 shares during the period. Citigroup […]
StockNews.com assumed coverage on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also commented on VCEL. Stephens upped their price target on Vericel from $39.00 to $42.00 in a research note on Thursday, […]